Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • BABA vs MRNA✓SelectedUSD · MRNABABA vs MRNA performance historyLatest closeAs of-2.68%11/20
Stock and ETF performance explorer

BABA vs MRNA

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
-36.9%
MRNA return
-27.3%
Excess return
-9.7%
Maximum drawdown
-56.8%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 5y.

Portfolio and benchmark returns by period
PeriodPortfolioMRNAExcessAlpha
1D-2.7%-2.2%-0.5%-2.5%
7D-14.1%-12.7%-1.4%-13.3%
30D-22.3%-20.7%-1.7%-21.3%
3M-37.9%+46.3%-84.1%-39.6%
6M-39.2%+305.2%-344.4%-50.1%
YTD-44.2%+561.2%-605.4%-59.0%
1Y-46.6%+772.1%-818.7%-63.0%
3Y+9.8%+147.0%-137.1%-10.2%
All-36.9%-27.3%-9.7%-44.2%

Cumulative growth

Daily Returns

Daily percentage return beside MRNA.

Daily Out/Under-Performance

Portfolio return minus MRNA return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × MRNA return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 5y: compounded portfolio wealth divided by compounded MRNA wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

5y analysis · Full analysis span regression · 6 months rolling